Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations.
Wang-Gohrke S, Weikel W, Risch H, Vesprini D, Abrahamson J, Lerman C, Godwin A, Moslehi R, Olipade O, Brunet JS, Stickeler E, Kieback DG, Kreienberg R, Weber B, Narod SA, Runnebaum IB.
Wang-Gohrke S, et al.
Br J Cancer. 1999 Sep;81(1):179-83. doi: 10.1038/sj.bjc.6690669.
Br J Cancer. 1999.
PMID: 10487631
Free PMC article.